Article and Video CATEGORIES
Dr. Chul Kim is an Associate Professor at Georgetown University focusing on thoracic oncology. His goal as a thoracic medical oncologist is to introduce innovative cancer therapies into clinical practice, and he is devoted to formulating clinical trials aimed at promoting personalized cancer treatments.
Korean: 종양학자들은 위험 요인, 표적 치료 옵션, 유전자 검사의 중요성 등 폐암 관련 주제에 대해 강연합니다.
In this video series, Dr. Chul Kim translates discussions on lung cancer in Korean. Videos include information on SCLC and NSCLC including statistics and risk factors.
To watch the full playlist click here.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…
That's just beautiful Linda. Thank you,